Global Poloxamer Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Poloxamer Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

According to APO Research, The global Poloxamer market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Poloxamer is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Poloxamer is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Poloxamer is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Poloxamer include BASF, Croda, Hubei Hengshuo, ADEKA, Solvay, Lakeland Chemicals, Nanjing Well and Merck KGaA, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope


This report aims to provide a comprehensive presentation of the global market for Poloxamer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poloxamer.
The Poloxamer market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poloxamer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

BASF
Croda
Hubei Hengshuo
ADEKA
Solvay
Lakeland Chemicals
Nanjing Well
Merck KGaA
Poloxamer segment by Type

Poloxamer 124
Poloxamer 188
Poloxamer 338
Poloxamer 407
Poloxamer 184
Others
Poloxamer segment by Application

Pharmaceutical Industry
Cosmetics Industry
Biologics
Others
Poloxamer Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers


High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poloxamer market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Poloxamer and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poloxamer.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Poloxamer manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Poloxamer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Poloxamer Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Poloxamer Sales Estimates and Forecasts (2019-2030)
1.3 Poloxamer Market by Type
1.3.1 Poloxamer 124
1.3.2 Poloxamer 188
1.3.3 Poloxamer 338
1.3.4 Poloxamer 407
1.3.5 Poloxamer 184
1.3.6 Others
1.4 Global Poloxamer Market Size by Type
1.4.1 Global Poloxamer Market Size Overview by Type (2019-2030)
1.4.2 Global Poloxamer Historic Market Size Review by Type (2019-2024)
1.4.3 Global Poloxamer Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Poloxamer Sales Breakdown by Type (2019-2024)
1.5.2 Europe Poloxamer Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Poloxamer Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Poloxamer Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Poloxamer Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Poloxamer Industry Trends
2.2 Poloxamer Industry Drivers
2.3 Poloxamer Industry Opportunities and Challenges
2.4 Poloxamer Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Poloxamer Revenue (2019-2024)
3.2 Global Top Players by Poloxamer Sales (2019-2024)
3.3 Global Top Players by Poloxamer Price (2019-2024)
3.4 Global Poloxamer Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Poloxamer Key Company Manufacturing Sites & Headquarters
3.6 Global Poloxamer Company, Product Type & Application
3.7 Global Poloxamer Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Poloxamer Market CR5 and HHI
3.8.2 Global Top 5 and 10 Poloxamer Players Market Share by Revenue in 2023
3.8.3 2023 Poloxamer Tier 1, Tier 2, and Tier 3
4 Poloxamer Regional Status and Outlook
4.1 Global Poloxamer Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Poloxamer Historic Market Size by Region
4.2.1 Global Poloxamer Sales in Volume by Region (2019-2024)
4.2.2 Global Poloxamer Sales in Value by Region (2019-2024)
4.2.3 Global Poloxamer Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Poloxamer Forecasted Market Size by Region
4.3.1 Global Poloxamer Sales in Volume by Region (2025-2030)
4.3.2 Global Poloxamer Sales in Value by Region (2025-2030)
4.3.3 Global Poloxamer Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Poloxamer by Application
5.1 Poloxamer Market by Application
5.1.1 Pharmaceutical Industry
5.1.2 Cosmetics Industry
5.1.3 Biologics
5.1.4 Others
5.2 Global Poloxamer Market Size by Application
5.2.1 Global Poloxamer Market Size Overview by Application (2019-2030)
5.2.2 Global Poloxamer Historic Market Size Review by Application (2019-2024)
5.2.3 Global Poloxamer Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Poloxamer Sales Breakdown by Application (2019-2024)
5.3.2 Europe Poloxamer Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Poloxamer Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Poloxamer Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Poloxamer Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 BASF
6.1.1 BASF Comapny Information
6.1.2 BASF Business Overview
6.1.3 BASF Poloxamer Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BASF Poloxamer Product Portfolio
6.1.5 BASF Recent Developments
6.2 Croda
6.2.1 Croda Comapny Information
6.2.2 Croda Business Overview
6.2.3 Croda Poloxamer Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Croda Poloxamer Product Portfolio
6.2.5 Croda Recent Developments
6.3 Hubei Hengshuo
6.3.1 Hubei Hengshuo Comapny Information
6.3.2 Hubei Hengshuo Business Overview
6.3.3 Hubei Hengshuo Poloxamer Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hubei Hengshuo Poloxamer Product Portfolio
6.3.5 Hubei Hengshuo Recent Developments
6.4 ADEKA
6.4.1 ADEKA Comapny Information
6.4.2 ADEKA Business Overview
6.4.3 ADEKA Poloxamer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ADEKA Poloxamer Product Portfolio
6.4.5 ADEKA Recent Developments
6.5 Solvay
6.5.1 Solvay Comapny Information
6.5.2 Solvay Business Overview
6.5.3 Solvay Poloxamer Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Solvay Poloxamer Product Portfolio
6.5.5 Solvay Recent Developments
6.6 Lakeland Chemicals
6.6.1 Lakeland Chemicals Comapny Information
6.6.2 Lakeland Chemicals Business Overview
6.6.3 Lakeland Chemicals Poloxamer Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lakeland Chemicals Poloxamer Product Portfolio
6.6.5 Lakeland Chemicals Recent Developments
6.7 Nanjing Well
6.7.1 Nanjing Well Comapny Information
6.7.2 Nanjing Well Business Overview
6.7.3 Nanjing Well Poloxamer Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Nanjing Well Poloxamer Product Portfolio
6.7.5 Nanjing Well Recent Developments
6.8 Merck KGaA
6.8.1 Merck KGaA Comapny Information
6.8.2 Merck KGaA Business Overview
6.8.3 Merck KGaA Poloxamer Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck KGaA Poloxamer Product Portfolio
6.8.5 Merck KGaA Recent Developments
7 North America by Country
7.1 North America Poloxamer Sales by Country
7.1.1 North America Poloxamer Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Poloxamer Sales by Country (2019-2024)
7.1.3 North America Poloxamer Sales Forecast by Country (2025-2030)
7.2 North America Poloxamer Market Size by Country
7.2.1 North America Poloxamer Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Poloxamer Market Size by Country (2019-2024)
7.2.3 North America Poloxamer Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Poloxamer Sales by Country
8.1.1 Europe Poloxamer Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Poloxamer Sales by Country (2019-2024)
8.1.3 Europe Poloxamer Sales Forecast by Country (2025-2030)
8.2 Europe Poloxamer Market Size by Country
8.2.1 Europe Poloxamer Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Poloxamer Market Size by Country (2019-2024)
8.2.3 Europe Poloxamer Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Poloxamer Sales by Country
9.1.1 Asia-Pacific Poloxamer Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Poloxamer Sales by Country (2019-2024)
9.1.3 Asia-Pacific Poloxamer Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Poloxamer Market Size by Country
9.2.1 Asia-Pacific Poloxamer Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Poloxamer Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Poloxamer Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Poloxamer Sales by Country
10.1.1 Latin America Poloxamer Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Poloxamer Sales by Country (2019-2024)
10.1.3 Latin America Poloxamer Sales Forecast by Country (2025-2030)
10.2 Latin America Poloxamer Market Size by Country
10.2.1 Latin America Poloxamer Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Poloxamer Market Size by Country (2019-2024)
10.2.3 Latin America Poloxamer Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Poloxamer Sales by Country
11.1.1 Middle East and Africa Poloxamer Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Poloxamer Sales by Country (2019-2024)
11.1.3 Middle East and Africa Poloxamer Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Poloxamer Market Size by Country
11.2.1 Middle East and Africa Poloxamer Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Poloxamer Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Poloxamer Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Poloxamer Value Chain Analysis
12.1.1 Poloxamer Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Poloxamer Production Mode & Process
12.2 Poloxamer Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Poloxamer Distributors
12.2.3 Poloxamer Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings